Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Avril Kaye Coley, M.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Avril Coley's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Avril Coley has written about over time.
Healthcare Disparities, 1 publications between 2023 and 2023, average publication date January 2023. Neoplasms, 1 publications between 2023 and 2023, average publication date January 2023. Humans, 2 publications between 2023 and 2024, average publication date November 2023. Carcinoma, Hepatocellular, 1 publications between 2024 and 2024, average publication date September 2024. Cell Communication, 1 publications between 2024 and 2024, average publication date September 2024. Endothelial Cells, 1 publications between 2024 and 2024, average publication date September 2024. Female, 1 publications between 2024 and 2024, average publication date September 2024. Gene Expression Profiling, 1 publications between 2024 and 2024, average publication date September 2024. Gene Expression Regulation, Neoplastic, 1 publications between 2024 and 2024, average publication date September 2024. Liver Neoplasms, 1 publications between 2024 and 2024, average publication date September 2024. Male, 1 publications between 2024 and 2024, average publication date September 2024. Prognosis, 1 publications between 2024 and 2024, average publication date September 2024. Signal Transduction, 1 publications between 2024 and 2024, average publication date September 2024.

To see the data from this visualization as text, click here.
Coley's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.